[{"indications": "Indications\u00a0hypertension", "name": "METHYLDOPA", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.2 Centrally acting antihypertensive drugs", "METHYLDOPA"], "cautions": "Cautions\u00a0monitor blood counts and liver-function\r\nbefore treatment and at intervals during first 6\u201312 weeks or if unexplained\r\nfever occurs; history of depression; positive direct Coombs\u2019 test in up to 20% of patients\r\n(may affect blood cross-matching); interference\r\nwith laboratory tests; interactions: Appendix 1 (methyldopa)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol may be enhanced", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances, dry mouth, stomatitis,\r\nsialadenitis; bradycardia, exacerbation of angina, postural hypotension,\r\noedema; sedation, headache, dizziness, asthenia, myalgia, arthralgia,\r\nparaesthesia, nightmares, mild psychosis, depression, impaired mental\r\nacuity, parkinsonism, Bell\u2019s palsy; hepatitis, jaundice; pancreatitis;\r\nhaemolytic anaemia; bone-marrow depression, leucopenia, thrombocytopenia,\r\neosinophilia; hypersensitivity reactions including lupus erythematosus-like\r\nsyndrome, drug fever, myocarditis, pericarditis; rashes (including\r\ntoxic epidermal necrolysis); nasal congestion, failure of ejaculation,\r\nimpotence, decreased libido, gynaecomastia, hyperprolactinaemia, amenorrhoea", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2553.htm", "doses": ["Initially 250\u00a0mg 2\u20133 times daily, increased gradually\r\nat intervals of at least 2 days, max. 3\u00a0g daily; elderly initially 125\u00a0mg twice daily, increased gradually, max. 2\u00a0g daily"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]